SCL
Stepan Company · Materials · Specialty Chemicals
Last
$50.90
−$0.43 (−0.84%) 4:00 PM ET
After hours $50.75 −$0.15 (−0.29%) 5:41 PM ET
Prev close $51.33
Open $50.01
Day high $51.47
Day low $50.00
Volume 160,227
Avg vol 202,691
Mkt cap
$1.15B
P/E ratio
24.83
FY Revenue
$2.33B
EPS
2.05
Gross Margin
11.57%
Sector
Materials
AI report sections
SCL
Stepan Company
Stepan Co. shows short-term price strength with the latest close above key moving averages and multiple bullish breakout signals, while longer-horizon returns over 6–12 months remain negative and below the 52-week midpoint. Fundamentals reflect modest revenue growth and improving operating cash flow alongside compressed profitability, weaker earnings, and thin free cash flow margins. Short interest is low in percentage terms but the elevated short volume ratio and overbought RSI point to near-term positioning and sentiment that could increase volatility.
AI summarized at 3:41 PM ET, 2026-01-07
AI summary scores
INTRADAY: 68 SWING: 59 LONG: 46
Volume vs average
Intraday (cumulative)
+4% (Above avg)
Vol/Avg: 1.04×
RSI
33.75 (Weak)
Weak (30–40)
MACD momentum
Intraday
-0.01 (Weak)
MACD: -0.03 Signal: -0.02
Short-Term
-2.16 (Weak)
MACD: 0.02 Signal: 2.17
Long-Term
-1.46 (Weak)
MACD: 3.11 Signal: 4.57
Intraday trend score 56.31

Latest news

SCL 12 articles Positive: 3 Neutral: 2 Negative: 1
Negative Investing.com • Bob Ciura
3 Best Dividend Kings for 2026

The article highlights three Dividend Kings—stocks with 50+ consecutive years of dividend increases—as attractive options for 2026. Becton, Dickinson & Co. (BDX) is a medical supply leader with strong earnings growth. H2O America (HTO) is a water utility benefiting from population growth in high-demand regions. Stepan Company (SCL) manufactures specialty chemicals but recently missed earnings estimates.

BDX HTO SCL Dividend Kings dividend growth passive income medical devices water utility
Sentiment note

Q3 2025 earnings significantly missed estimates by 13 cents on EPS. Surfactants segment faced volume contraction and rising raw material costs. Polymers segment declined 4% year-over-year with margin pressures.

Positive Investing.com • Bob Ciura
3 Small Cap Stocks With Consistent Dividends and Above-Market Yields

The article highlights three small-cap stocks with consistent dividend histories and above-market yields: Universal Corporation, Apollo Bancorp, and Stepan Company, each offering unique investment characteristics in their respective industries.

UVV APLO SCL small-cap stocks dividends Russell 2000 tobacco banking
Sentiment note

Strong competitive advantage with diverse global customer base, 57-year dividend increase history, and secure dividend payout ratio of 48%

Positive Benzinga • Prnewswire
Stepan Declares Quarterly Dividend

Stepan Company (SCL) has declared a quarterly cash dividend of $0.385 per share, payable on June 13, 2025, to common stockholders of record on May 30, 2025. This marks the 57th consecutive year that the company has increased its cash dividend to stockholders.

SCL Stepan Company dividend quarterly dividend
Sentiment note

The company has declared a quarterly cash dividend and has increased its dividend for 57 consecutive years, indicating financial stability and a commitment to shareholder returns.

Neutral GlobeNewswire Inc. • Researchandmarkets.Com
Lipids Industry Trends and Company Analysis 2025-2033, Featuring NOF Corporation, Stepan Company, Archer Daniels Midland, Cargill, Kerry Group, BASF, Merck, Koninklijke DSM

The global lipids market is expected to grow from $14.62 billion in 2024 to $26.38 billion in 2033, driven by increasing demand for functional lipids like omega-3 fatty acids and plant-based oils. Key players in the industry include NOF Corporation, Stepan Company, Archer Daniels Midland, Cargill, Kerry Group, BASF, Merck, and Koninklijke DSM.

SCL ADM MRK KRYAY lipids functional lipids plant-based oils omega-3 fatty acids
Sentiment note

The article mentions Stepan Company as one of the key players in the lipids industry without any additional details.

Positive GlobeNewswire Inc. • Researchandmarkets.Com
Sodium Lauryl Ether Sulfate (SLES) Global Strategic Business Report 2023-2024 & 2030 Featuring Key Players - BASF, Dow, DuPont de Nemours, Evonik Industries, Huntsman International, Solvay, and Stepan

The global market for Sodium Lauryl Ether Sulfate (SLES) is projected to reach $2 billion by 2030, driven by rising demand for personal care and cleaning products, technological advancements in mild and sustainable surfactants, and the expansion of e-commerce. The report highlights key players in the industry and analyzes market trends and growth opportunities.

BASFY DOW DD SLVYY Sodium Lauryl Ether Sulfate SLES personal care cleaning products
Sentiment note

Stepan Company is mentioned as one of the key players in the SLES market, indicating its strong presence and potential for growth in the industry.

Neutral GlobeNewswire Inc. • Global Market Insights Inc.
Alkyl Polyglucosides Market to exceed USD 1.1 Billion by 2032, Says Global Market Insights inc. - GlobeNewswire

The alkyl polyglucosides market is expected to reach over $1.1 billion by 2032, driven by the rising demand for environmentally friendly and sustainable surfactants across various sectors. The growing appeal of cornstarch-based products and the increasing use in agricultural chemicals are key factors driving the market growth.

BASFY CLZNY HUN SCL alkyl polyglucosides surfactants personal care household cleaning
Sentiment note

The article mentions Stepan Company as one of the leading firms in the alkyl polyglucosides industry, but does not provide any specific details about the company's involvement or plans.

Unknown Seeking Alpha • Justin Law
Dividend Champion, Contender, And Challenger Highlights: Week Of May 26

Stay up-to-date on dividend activity, changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers in our weekly summary.

EQH FLO HLNE LII
Unknown Zacks Investment Research • Zacks Equity Research
Stepan Co. (SCL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Stepan Co. (SCL) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

SCL
Unknown Zacks Investment Research • Zacks Equity Research
Stepan Co. (SCL) Surpasses Q1 Earnings Estimates

Stepan Co. (SCL) delivered earnings and revenue surprises of 82.86% and 4.24%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

SCL KOP
Unknown Zacks Investment Research • Zacks Equity Research
DuPont de Nemours (DD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

DuPont de Nemours (DD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DD SCL
Unknown Zacks Investment Research • Zacks Equity Research
Stepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SCL CC
Unknown Zacks Investment Research • Zacks Equity Research
Here's What Key Metrics Tell Us About Stepan Co. (SCL) Q4 Earnings

The headline numbers for Stepan Co. (SCL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

SCL
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal